These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2042796)

  • 41. [Evaluation of the Doppler-pulse volume recorder in Raynaud's phenomenon].
    Sciannameo F; Tazza D; Alberti D; Marianeschi P; Cao PG; Francucci M
    Arch Sci Med (Torino); 1983; 140(4):353-6. PubMed ID: 6673699
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differentiation of primary and secondary Raynaud's disease by carotid arterial stiffness.
    Cheng KS; Tiwari A; Boutin A; Denton CP; Black CM; Morris R; Seifalian AM; Hamilton G
    Eur J Vasc Endovasc Surg; 2003 Apr; 25(4):336-41. PubMed ID: 12651172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [New treatments for Raynaud's syndrome].
    Bellucci S; Kedra W; Ajzenberg N; Tobelem G; Caen J
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):103-7. PubMed ID: 3290833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serotonin and Raynaud's phenomenon.
    Seibold JR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S95-8. PubMed ID: 2412070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ketanserin and guanethidine in the treatment of causalgia.
    Davies JA; Beswick T; Dickson G
    Anesth Analg; 1987 Jun; 66(6):575-6. PubMed ID: 3578868
    [No Abstract]   [Full Text] [Related]  

  • 47. Reactive hyperemia in patients with Raynaud's phenomenon.
    Russell A; Kappagoda T
    J Rheumatol; 1988 Nov; 15(11):1653-7. PubMed ID: 3236299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Raynaud's phenomenon with captopril.
    Tosi S; Marchesoni A; Messina K; Bellintani C; Sironi G; Faravelli C
    Drugs Exp Clin Res; 1987; 13(1):37-42. PubMed ID: 3297593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of digital artery adrenoceptors in Raynaud's disease.
    Cooke JP; Creager SJ; Scales KM; Ren C; Tsapatsaris NP; Beetham WP; Creager MA
    Vasc Med; 1997; 2(1):1-7. PubMed ID: 9546943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The origin of Raynaud's phenomenon.
    Nielubowicz J; Zajaç S; Szamowska R; Adamski M
    J Cardiovasc Surg (Torino); 1978; 19(6):607-14. PubMed ID: 739033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Total and capillary fingertip blood flow in Raynaud's phenomenon.
    Coffman JD; Cohen AS
    N Engl J Med; 1971 Jul; 285(5):259-63. PubMed ID: 5090397
    [No Abstract]   [Full Text] [Related]  

  • 52. [Digital blood flow measurement by venous occlusion plethysmography in Raynaud's phenomenon. Value of the rewarming test].
    Cristol R; Debray J
    J Mal Vasc; 1986; 11(1):85-9. PubMed ID: 3944527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ketanserin (5 HT2-antagonist) in secondary Raynaud's phenomenon.
    Bounameaux HM; Hellemans H; Verhaeghe R; Dequeker J
    J Cardiovasc Pharmacol; 1984; 6(5):975-6. PubMed ID: 6209510
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of local temperature versus sympathetic tone on digital perfusion in Raynaud's phenomenon.
    Engelhart M; Seibold JR
    Angiology; 1990 Sep; 41(9 Pt 1):715-23. PubMed ID: 2221472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and image improvement of Raynaud's phenomenon after botulinum toxin type A treatment.
    Zhao H; Lian Y
    Australas J Dermatol; 2015 Aug; 56(3):202-5. PubMed ID: 25817568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Medical treatment of Raynaud's syndrome].
    Larbre JP; Nicolas JF; Larbre B; Perret-Liaudet P; Adam C; Thivolet J
    Rev Med Interne; 1988; 9(4):429-34. PubMed ID: 3065874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker.
    Rupp PA; Mellinger S; Kohler J; Dorsey JK; Furst DE
    J Rheumatol; 1987 Aug; 14(4):745-50. PubMed ID: 3312603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Validity of plethysmography and the digital temperature recovery test in the diagnosis of primary and occupational Raynaud's phenomenon].
    Laroche GP; Thériault G
    Clin Invest Med; 1987 Mar; 10(2):96-102. PubMed ID: 3581549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E; Devulder B
    Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Esophageal hypomotility in primary and secondary Raynaud's phenomenon: comparison of esophageal scintigraphy with manometry.
    Limburg AJ; Beekhuis H; Smit AJ; Kallenberg CG; Piers DA; Kleibeuker JH
    J Nucl Med; 1995 Mar; 36(3):451-5. PubMed ID: 7884508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.